Industry

LOS ANGELES–(BUSINESS WIRE)–The AIDS Healthcare Foundation (AHF) is urging governments meeting in Yaoundé, Cameroon, at the WTO 14th Ministerial Conference to ensure the continuation of the longstanding moratorium on certain intellectual property disputes—known as “non-violation complaints”—under the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). This moratorium has helped protect countries … [Read more…]

Jason Richardson Named Chief Financial Officer, Succeeding Michael Bourque Dominic Hulton Named Chief Marketing Officer Corey Moritz Appointed Vice President, U.S. Business to Business Sales BEVERLY, Mass.–(BUSINESS WIRE)–$INGN #AirwayClearance—Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the following leadership appointments designed to accelerate … [Read more…]

MINNEAPOLIS–(BUSINESS WIRE)–Provation, a leading provider of clinical productivity software, announces the launch of Provation® Mira Documentation Assist, a voice-driven documentation capability within its cloud-based GI procedure platform, Provation® Apex, enabling real-time structured documentation during procedures. This hands-free technology allows clinicians to document in real-time by simply speaking, reducing the need for manual data entry and … [Read more…]

New collection closes the gap between leadership development and well-being support as organizations seek to strengthen leaders and consolidate fragmented point solutions SAN FRANCISCO–(BUSINESS WIRE)–As rising healthcare costs, workforce stress, and constant organizational change place increasing pressure on managers and leaders, employers are rethinking how they develop talent. Today, Modern Health, a leading global workplace … [Read more…]

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that preclinical data from the Company’s STAT6 inhibitor program will be presented in four posters at IMMUNOLOGY2026™, the annual meeting of the American Association of Immunologists (AAI), being held April 15-19, … [Read more…]

FRANKFURT, Germany–(BUSINESS WIRE)–Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is pleased to announce that BELOTERO® Balance has received EU approval for two additional indications: the treatment of infraorbital hollow (including the tear trough) and horizontal forehead lines1*. “With these new approvals, BELOTERO® Balance further strengthens its position as a versatile hyaluronic acid dermal … [Read more…]

Trial met its primary endpoint, demonstrating clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at Week 28 Results demonstrate the potential for Camzyos to be the first targeted pharmacological therapy for the treatment of oHCM in adolescents Safety profile of Camzyos in adolescents was similar to established profile in … [Read more…]

Patients treated with tonlamarsen experienced statistically significant reductions in plasma angiotensinogen levels and clinically meaningful changes in systolic blood pressure Results support initiation of Phase 2b clinical trial of tonlamarsen in patients with acute severe hypertension SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.–(BUSINESS WIRE)–#ACC26—Kardigan™, a clinical-stage precision therapeutics company developing medicines that target the root … [Read more…]

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD) that detects early signs of PH, a serious and progressive condition affecting the lungs and right side of the heart. The algorithm, which previously received FDA Breakthrough … [Read more…]